Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 7 Feb 20 RW Registration withdrawal request
- 6 Feb 20 EFFECT Notice of effectiveness
-
3 Feb 20 F-1 Registration statement (foreign)
BNTX similar filings
- 22 Jul 20 Registration statement (foreign) (amended)
- 21 Jul 20 Registration statement (foreign)
- 21 Jul 20 Registration statement (foreign)
- 3 Feb 20 Registration statement (foreign)
- 9 Oct 19 Registration statement (foreign) (amended)
- 4 Oct 19 Registration statement (foreign) (amended)
- 24 Sep 19 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form F-1 of BioNTech SE of our report dated March 11, 2019, except with respect to the matters that raise substantial doubt about the Company’s ability to continue as a going concern discussed in Note 1, as to which the date is January 27, 2020, relating to the financial statements of Neon Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 3, 2020